Gross Profit - Devyser Diagnostics AB (STO:DVYSR) - Alpha Spread
D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 117.5 SEK 0.43% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Devyser Diagnostics AB
Gross Profit Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Gross Profit
kr144.8m
CAGR 3-Years
45%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Gross Profit
kr950.2m
CAGR 3-Years
20%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Gross Profit
kr678m
CAGR 3-Years
56%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Gross Profit
kr2B
CAGR 3-Years
30%
CAGR 5-Years
19%
CAGR 10-Years
20%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Gross Profit
kr18.4B
CAGR 3-Years
17%
CAGR 5-Years
17%
CAGR 10-Years
29%
BioArctic AB
STO:BIOA B
Gross Profit
kr565.1m
CAGR 3-Years
144%
CAGR 5-Years
-4%
CAGR 10-Years
N/A

See Also

What is Devyser Diagnostics AB's Gross Profit?
Gross Profit
144.8m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Gross Profit amounts to 144.8m SEK.

What is Devyser Diagnostics AB's Gross Profit growth rate?
Gross Profit CAGR 5Y
35%

Over the last year, the Gross Profit growth was 40%. The average annual Gross Profit growth rates for Devyser Diagnostics AB have been 45% over the past three years , 35% over the past five years .

Back to Top